Isolation and Identification of Extracellular Vesicles

Abstract:

Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are secreted by cells under normal and pathological conditions. EVs have attracted increasing attention due to their potential roles in intercellular communication and disease pathogenesis. In this review, we summarize current methods for isolation and characterization of EVs, with a focus on exosomes. We also discuss their potential applications in clinical diagnosis and therapy.

Introduction:

EVs are a heterogeneous group of membrane-bound particles released by cells, including exosomes (diameter 30-150 nm), microvesicles (100-1000 nm), and apoptotic bodies (500-2000 nm) [1]. They contain lipids, proteins, and nucleic acids, which can be transferred to recipient cells and modulate intercellular communication. EVs have emerged as important mediators in various biological processes, including immune response, angiogenesis, and cancer development [2]. However, their isolation and characterization are still challenging due to their small size and heterogeneity.

Isolation of EVs:

Various methods have been developed for EV isolation, including ultracentrifugation, size exclusion chromatography, immune-affinity capture, and microfluidics [3]. Ultracentrifugation is the most commonly used method for EV isolation, but it requires large sample volumes and is time-consuming. Size exclusion chromatography can separate EVs based on size, but it may also exclude smaller EVs that are of biological relevance. Immune-affinity capture is a relatively new method that utilizes specific antibodies to capture EVs, but it is limited by the availability and specificity of antibodies. Microfluidics can isolate EVs based on size and surface markers, but it requires specialized equipment and expertise.

Characterization of EVs:

Characterization of EVs is essential for understanding their biological functions and clinical applications. The most commonly used methods for EV characterization are electron microscopy, nanoparticle tracking analysis, and Western blotting [4]. Electron microscopy can visualize EV morphology and size, but it does not provide information on the protein and nucleic acid content of EVs. Nanoparticle tracking analysis can measure EV size and concentration, but it may underestimate the number of smaller EVs. Western blotting can detect specific EV-associated proteins, but it requires prior knowledge of the proteins of interest.

Exosomes:

Exosomes are a type of EVs that are derived from the endocytic pathway and are enriched in certain proteins and lipids, such as tetraspanins, Alix, and TSG101 [5]. Exosomes play a role in intercellular communication by transferring bioactive molecules, including miRNAs, proteins, and lipids, to recipient cells [6]. Exosomes have been implicated in various diseases, including cancer, infectious diseases, and neurodegenerative disorders.

Clinical applications:

EVs have potential applications in clinical diagnosis and therapy. EVs can serve as biomarkers for various diseases, including cancer, cardiovascular diseases, and neurological disorders [7]. EVs can also be used as drug delivery vehicles for targeted therapy. However, there are still challenges to be overcome, such as standardized EV isolation and characterization methods and large-scale production of EVs for clinical applications.

Conclusion:

In conclusion, EVs are important mediators in intercellular communication and disease pathogenesis. Isolation and characterization of EVs, particularly exosomes, are essential for understanding their biological functions and clinical applications. Advances in EV research may provide diagnostic and therapeutic opportunities for various diseases.

References:

1. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.

2. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255-89.

3. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3.22.

4. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.

5. van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213-28.

6. EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347-57.

7. Zhang P, Zhou X, He M. Clinical translation of extracellular vesicle-based cancer liquid biopsy: are we there yet? Ann Transl Med. 2018;6(16):328.